Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
This is the second US FDA GMP inspection of this facility within one year
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Subscribe To Our Newsletter & Stay Updated
